Search by Drug Name or NDC

    NDC 65219-0445-22 Etomidate 2 mg/mL Details

    Etomidate 2 mg/mL

    Etomidate is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Fresenius Kabi USA, LLC. The primary component is ETOMIDATE.

    Product Information

    NDC 65219-0445
    Product ID 65219-445_446487f1-002e-41d3-846a-67570e797171
    Associated GPIs 70400010002020
    GCN Sequence Number 030871
    GCN Sequence Number Description etomidate VIAL 2 MG/ML INTRAVEN
    HIC3 H2C
    HIC3 Description GENERAL ANESTHETICS,INJECTABLE
    GCN 12831
    HICL Sequence Number 001554
    HICL Sequence Number Description ETOMIDATE
    Brand/Generic Generic
    Proprietary Name Etomidate
    Proprietary Name Suffix n/a
    Non-Proprietary Name Etomidate
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SOLUTION
    Route INTRAVENOUS
    Active Ingredient Strength 2
    Active Ingredient Units mg/mL
    Substance Name ETOMIDATE
    Labeler Name Fresenius Kabi USA, LLC
    Pharmaceutical Class General Anesthesia [PE], General Anesthetic [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA215028
    Listing Certified Through 2024-12-31

    Package

    NDC 65219-0445-22 (65219044522)

    NDC Package Code 65219-445-22
    Billing NDC 65219044522
    Package 10 VIAL, SINGLE-DOSE in 1 CARTON (65219-445-22) / 10 mL in 1 VIAL, SINGLE-DOSE (65219-445-12)
    Marketing Start Date 2023-10-01
    NDC Exclude Flag N
    Pricing Information N/A